SER · Serina Therapeutics, Inc. · Executive Compensation
$1.73
+0.09 (+5.49%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that our existing cash and cash equivalents are not expected to be sufficient to fund our operations for the 12 months following the issuance of our unaudited condensed consolidated financial statements for the period ended June 30, 2026, and that substantial doubt about our ability to continue as a going concern continues to exist.”View the 10-Q filed Aug 13, 2026
Market Cap
$44.45M
Shares
25.40M
Volume · Oct 29
18.31K
Avg daily vol (3M)
66.26K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steve Ledger | Chief Executive Officer | $637,500 |
| Randall Moreadith | M.D., Ph.D. Chief Development Officer | $563,200 |
| Srini Tenjarla | Chief Technical Operations Officer | $527,400 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steve Ledger | Chief Executive Officer | $3,703,621 |
| Srini Tenjarla | Senior Vice President of CMC and Formulation | $1,781,288 |
| Gregory S. Curhan | Chief Financial Officer — | $1,700,413 |
| Joanne M. Hackett | Former Interim Chief Executive Officer | $51,183 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $1,059,269 |
| Randall Moreadith | M.D., Ph.D. Chief Development Officer Legacy Serina’s President and CEO | $433,880 |
| Tacey Viegas | Former Chief Operating Officer | $356,526 |
| Nafees N. Malik | Chief Operating Officer | $302,151 |
| Andrea E. Park | Chief Financial Officer | $298,556 |
| Steve Ledger | Chief Executive Officer | $237,500 |
| Joanne M. Hackett | Former Interim Chief Executive Officer | $102,850 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $562,032 |
| Randall Moreadith | M.D., Ph.D. Chief Development Officer Legacy Serina’s President and CEO | $362,898 |
| Tacey Viegas | Former Chief Operating Officer | $299,480 |
| Andrea E. Park | Chief Financial Officer | $295,289 |
| Nafees N. Malik | Chief Operating Officer | $282,272 |
| Joanne M. Hackett | Interim Chief Executive Officer | $103,065 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $698,783 |
| Nafees N. Malik | Chief Operating Officer | $368,210 |
| Andrea E. Park | Chief Financial Officer | $365,258 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $561,032 |
| Andrea E. Park | Chief Financial Officer | $437,871 |
| Nafees N. Malik | Chief Operating Officer | $282,272 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $1,041,701 |
| Nafees N. Malik | Chief Operating Officer | $518,993 |
| Hal Sternberg | Vice President, Research | $329,023 |
| Andrea E. Park | Chief Financial Officer | $94,139 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Michael D. West | Chief Executive Officer | $1,650,407 |
| Nafees N. Malik | Chief Operating Officer | $782,240 |
| Hal Sternberg | Vice President, Research | $296,993 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Farrell Simon | Member of the Board of Directors | Appointed | 2026-07-22 |
| Srini Tenjarla, Ph.D. | Chief Technology Officer | Appointed | 2026-04-21 |
| Lead Investor | Co-Chairman of the Company | Appointed | 2026-03-23 |
| Gregory H. Bailey | Co-Chairman of the Board | Appointed | 2026-03-23 |
| Stephen Brannan, M.D. | Member of the Board of Directors | Appointed | 2025-05-22 |
| Dr. Jay Venkatesan | Member of the Board of Directors | Appointed | 2025-02-12 |
| Karen J. Wilson | Member of the Board of Directors | Appointed | 2025-01-15 |
| Steven Mintz | Director | Appointed | 2024-12-18 |
| Remy Gross | Director | Appointed | 2024-12-18 |
| Balkrishan "Simba" Gill | Director | Appointed | 2024-12-18 |
| Steven Ledger | Chief Executive Officer | Appointed | 2024-09-12 |
| Gregory S. Curhan | Chief Financial Officer | Appointed | 2024-08-16 |
| Srini Tenjarla | Senior Vice President, CMC & Formulation | Appointed | 2024-07-18 |
| Tacey Viegas | Chief Operating Officer | Retired | 2024-07-12 |
| Simba Gill | Chairman of the Board of Directors | Appointed | 2024-04-17 |
| Jean-Christophe Renondin | board of directors | Resigned | 2024-04-01 |
| Joanne M. Hackett | board of directors | Resigned | 2024-04-01 |
| Joanne M. Hackett | interim CEO | Terminated | 2024-04-01 |
| J. Milton Harris | Class II Director | Appointed | 2024-04-01 |
| Richard Marshall | Class III Director | Appointed | 2024-04-01 |
| J. Milton Harris | Chairman of the Board | Appointed | 2024-04-01 |
| Remy Gross | Class I Director | Appointed | 2024-04-01 |
| Tacey Viegas | Chief Operating Officer; Secretary | Appointed | 2024-04-01 |
| Randall Moreadith | Chief Scientific Officer | Appointed | 2024-04-01 |
| Andrea E. Park | Interim Chief Financial Officer | Appointed | 2024-04-01 |
Leadership
- Joanne M. Hackett CEO
- Steve Ledger CEO
- Steven Ledger CEO, Board Member
- Gregory H. Bailey Chairman, Board Member
- J. Milton Harris Chairman, Board Member
- Lead Investor Chairman
- Simba Gill Chairman
- Simba Gill, Ph.D. Chairman
- Andrea E. Park CFO, Chief Accounting Officer
- Andrea Park CFO, Chief Accounting Officer
- Gregory S. Curhan CFO
- Nafees N. Malik COO
- Tacey Viegas COO
- Srini Tenjarla, Ph.D. CTO
- Balkrishan "Simba" Gill Board Member
- Dr. Jay Venkatesan Board Member
- Farrell Simon Board Member
- Gregory Bailey Board Member
- Joanne Hackett Board Member
- Karen J. Wilson Board Member
- Michael D. West Board Member
- Michael H. May Board Member
- Michael May Board Member
- Remy Gross Board Member
- Richard Marshall Board Member
- Stephen Brannan Board Member
- Stephen Brannan, M.D. Board Member
- Steven Mintz Board Member